Use caution if coadministration of maraviroc prescription diltiazem is component, due Diacordin a possible increase in maraviroc exposure. Avoid coadministration of diltiazem and phenytoin due to decreased plasma concentrations of diltiazem. In addition, diltiazem inhibits CYP3A4, a partial pathway for propafenone metabolism.
Possible side effects of Diacordin include:
Diacordin is used to treat diseases such as: Angina Pectoris Prophylaxis, Atrial Fibrillation, Atrial Flutter, Heart Failure, High Blood Pressure, Raynaud's Syndrome, Supraventricular Tachycardia.
Total daily dose should not exceed 6 mg. The dose may be increased slowly over time until treatment goals are achieved.